Published on : Feb 15, 2016
ALBANY, New York, Feb 15, 2016: ResearchMoz.us has announced the addition of a new market study, titled “Stem Cell Research Products - Opportunities, Tools, and Technologies 2016,” to its repertoire. The report provides a comprehensive overview of the global market for stem cell research products, covering aspects such as market definition, segmentation, and the factors influencing its growth trajectory.
It includes exhaustive information to help industry stakeholders understand the unique opportunities in the stem cell industry. The report provides information on how to derive more revenue from the sale of relevant products to stem cell scientists. The report also includes valuable data enabling leading enterprises in the market to identify new product development opportunities and thus gain a competitive edge.
Stem cells are primitive cells that are found in all multicellular organisms. These cells are characterized by the ability of cell renewal and their capacity to mature into different cell types.
Click here to get more info with TOC in a PDF Format: http://www.researchmoz.us/enquiry.php?type=S&repid=550905
Stem cell research and experimentation has been underway for over five decades, due to the potentially massive medical benefits of the unique ability of stem cells to repeatedly divide and replicate and morph into a range of human cells. Furthermore, the “unspecialized” nature of stem cells allows them to differentiate into a wide range of specialized cell types. Traditionally, scientists have been experimenting on both adult and embryonic stem cells as research tools. While embryonic cells have the ability to differentiate between multiple types of cells, there have been significant moral, spiritual, and ethical controversies surrounding the appropriateness of using these cells for research purposes. Although a few types of adult cells exhibit differentiation capacity, it is likely to be limited.
By 2007, Kyoto University conducted a series of follow-up experiments, which transformed the human adult cells into iPSC cells. Nearly at the same time, a group of research scientists at the University of Wisconsin-Madison, led by James Thomson, accomplished the same experiment by deriving iPSC lines from human somatic cells.
The possibilities arising from such experiments have resulted in substantial commercial interest, with potential applications of stem cells ranging from their use in the treatment and reversal of diseases to more targeted pharmacological testing, targeted cell therapy, and tissue regeneration. The rising incidence of Parkinson’s disease, spinal cord injuries, and Huntington’s disease, in which clinical applications of stem cells could offer benefits in reversing or halting the side effects, is also giving impetus to the demand for stem cell research.
To provide an executive-level blueprint of the global market for stem cell research products, the report closely studies the strategies adopted by the leading companies operating in the market. Acquisition is a popular strategy adopted by several market players to grow their business and capture a larger market share. Merck KGaA, in particular, has exhibited a strong commitment to this approach, expanding its reach by acquiring several other prominent players in the stem cell research products market.
The report provides a comprehensive analysis of the latest developments in the market and trends impacting its trajectory over the years. To provide an in-depth analysis, results from the end user survey conducted on stem cell scientists are included in the report.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org